| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
2 companies
Powl Brian T. is a Chief Commercial Officer at Kura Oncology, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | KURA Kura Oncology, Inc. | Chief Commercial Officer | Sell | 8,887 | $11.18 | $99,329.11 | -6.0% | -28.4% | - | |
| Sep 29, 2025 | KURA Kura Oncology, Inc. | Chief Commercial Officer | Sell | 8,891 | $8.94 | $79,505.10 | -8.2% | +16.5% | - | |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | Chief Commercial Officer | Sell | 1,583 | $7.87 | $12,461.22 | -2.6% | -16.2% | +3.5% | |
| Jul 5, 2023 | FATE Fate Therapeutics Inc | Chief Commercial Officer | Sell | 3,854 | $4.87 | $18,768.98 | -8.6% | -62.1% | -34.8% |